NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy

Despite the development of many anticancer agents over the past 20 years, ovarian cancer remains the most lethal gynecologic malignancy. Due to a lack of effective screening, the majority of patients with ovarian cancer are diagnosed at an advanced stage, and only ~20% of patients are cured. Thus, i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cornejo, Yvonne, Li, Min, Dellinger, Thanh H., Mooney, Rachael, Rahman, Masmudur M., McFadden, Grant, Aboody, Karen S., Hammad, Mohamed
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771716/
https://ncbi.nlm.nih.gov/pubmed/33473255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27845
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars